Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Apply
INV-1120 & Pembrolizumab
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step